definiens: shall mean any C P that ( 1 ) is ( A ) developed by or on behalf of [COMPANY] or any of its Affiliates ( al one or together with a Third Party ), ( B ) Directed t o a [COMPANY] Ex - Vivo Target, and ( C ) is an edited Perm itted Cell Type that has been manufactured or modified from any cell using CRISPR - Cas where such modification is conducted ex vivo for the purpose of reintroducing such modified cells into a patient, and ( 2 ) either ( A ) the manufacture, use, offer fo r sale, sale, import, development or commercialization of w hich would ( absent any license or ownership interes t thereto ) infringe any Intellia Ex - Vivo Patent Right s, or ( B ) incorporates Intellia Ex - Vivo Know - How or directly uses Intellia Ex - Vivo Know - How provided in tangible form in the Manufacture of such CP . For clarity, [COMPANY] Ex - Vivo Products shall exclude R egeneron Products